A solution to the postantibiotic era: phages as precision medicine

Area of Science:

• Microbiology
• Biotechnology
• Genetics

Background:

• Antibiotic-resistant bacterial infections represent a critical global health threat.
• Phage therapy, using bacteriophages (phages) to target bacteria, is a promising alternative to conventional antibiotics.
• Phages selectively eliminate pathogens while preserving beneficial gut microbiota.

Purpose of the Study:

• To highlight the potential of phage therapy as a precision medicine solution.
• To discuss recent advancements in genetic engineering, synthetic biology, and artificial intelligence (AI) driving phage therapy innovation.
• To explore how engineered phages and AI-driven approaches can overcome bacterial resistance mechanisms.

Main Methods:

• Review of recent advances in phage engineering for enhanced efficacy and host range.
• Application of artificial intelligence and machine learning for identifying optimal phage candidates and designing phage cocktails.
• Discussion of engineered phage capabilities, including overcoming bacterial immune systems and modulating bacterial hosts.

Main Results:

• Engineered phages can be customized for broader host targeting and enhanced efficacy.
• AI and machine learning accelerate the discovery of effective phage candidates and personalized phage cocktails.
• Phage therapy is evolving into a precision medicine strategy.

Conclusions:

• Phage therapy, enhanced by genetic engineering and AI, presents a viable solution to the antibiotic resistance crisis.
• Tailored phage therapies offer a promising avenue for combating challenging bacterial infections.
• Continued innovation in phage technology is crucial for addressing global health challenges.